United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

These data were reported to the NYC DOHMH by March 31, 2021 This dataset includes data on new diagnoses of HIV and AIDS in NYC for the calendar years 2016 through 2020. Reported cases and case rates (per 100,000 population) are stratified by United Hospital Fund (UHF) neighborhood, age group, and race/ethnicity. Note: - Cells marked "NA" cannot be calculated because of cell suppression or 0 denominator.

These data were reported to the NYC DOHMH by March 31, 2021

This dataset includes data on new diagnoses of HIV and AIDS in NYC for the calendar years 2016 through 2020. Reported cases and case rates (per 100,000 population) are stratified by United Hospital Fund (UHF) neighborhood, sex, and race/ethnicity.

HIV/AIDS data from the HIV Surveillance Annual Report Data reported to the HIV Epidemiology Program by March 31, 2022. All data shown are for people ages 18 and older. Borough-wide and citywide totals may include cases assigned to a borough with an unknown UHF or assigned to NYC with an unknown borough, respectively. Therefore, UHF totals may not sum to borough totals and borough totals may not sum to citywide totals.""

This directory is for at-risk for HIV and eligible persons living with HIV in New York City seeking HIV medical and supportive services. The agencies and their listed programs receive CDC and Ryan White Part-A funding to provide: Targeted-Testing among Priority Populations, Food and Nutrition Services, Health Education and Risk Reduction Services, Harm Reduction Services, Legal Services, Mental Health Services, Case Management and Care Coordination Services, and Supportive Counseling Services. To be eligible to recieve these services, prospective clients must: 1)be HIV-positive; 2) have a total household income below 435% of the Federal Poverty Level (FPL) (this is the same as the income eligible guidelines for the New York State AIDS Drug Assistance Program (ADAP) and higher than the income eligiblity guidelines for Medicaid in New York State); and 3) reside in New York City or the counties of Westchester, Rockland, and Putnam. For providers, to make a referral, please contact the program directly using the information provided in the diretory (please be sure to call before directing clients to the program). When making a referral, you may also find it useful to talk to your client about executing a release of information form authorizing you to share confidential health and HIV-related information with another service provider in order to coordinate care (for more information, go to https://www.health.ny.gov/diseases/aids/providers/forms/informedconsent.htm).

New HIV infections (per 1000 uninfected population) for African Countries

  Dataset Description

This dataset contains 'New HIV infections (per 1000 uninfected population)' data for all 54 African countries, sourced from the World Health Organization (WHO). The data is structured with years as rows and countries as columns, facilitating time-series analysis. The data is measured in: per 1000 uninfected population. Missing values have been handled using linear interpolation… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/New-Hiv-Infections-Per-1000-Uninfected-Population-for-African-Countries.

license: apache-2.0 tags: - africa - sustainable-development-goals - world-health-organization - development

  New HIV infections (per 1000 uninfected population)





  Dataset Description

This dataset provides country-level data for the indicator "3.3.1 New HIV infections (per 1000 uninfected population)" across African nations, sourced from the World Health Organization's (WHO) data portal on Sustainable Development Goals (SDGs). The data is presented in a wide… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/hiv-infections-for-african-countries.

This data set provides an estimate of the number of people living with Human Immunodeficiency Virus (HIV) Disease at the end of each year for 2012 through 2016 and the number of these persons who have injection drug use identified as the primary risk for having acquired the infection. The data sets also provides the number of new diagnoses of HIV Disease by county among all persons and among those with injection drug identified as the primary risk. These data are derived through HIV surveillance activities of the Pennsylvania Department of Health. Laboratories and providers are required to report HIV test results for all individuals with a result that indicates the presence of HIV infection. These include detectable viral load results and CD4 results below 200 cells. These data are reported electronically to the Pennsylvania National Electronic Disease Surveillance System. The most recent patient address information obtained from all reports (both HIV and non-HIV reports) is used to identify last known county of residence in 2016. Cases are also matched to lists that identify individuals who have been reported to be living outside of Pennsylvania by the US Centers for Disease Control and Prevention (CDC) to remove cases that are presumed to have moved from Pennsylvania. Address data for Philadelphia County cases are extracted from the Pennsylvania enhanced HIV/AIDS Reporting System.

IDU: use of non-prescribed injection drugs (e.g., heroin, fentanyl, cocaine, etc.)

HIV Disease: Confirmed infection with the Human Immunodeficiency Virus (HIV). Acquired Immunodeficiency Syndrome (AIDS) is a stage of HIV Disease marked by a low CD4 count and/or certain co-morbid conditions.

license: apache-2.0 tags: - africa - sustainable-development-goals - world-health-organization - development

  New HIV infections (per 1000 uninfected population) - Male





  Dataset Description

This dataset provides country-level data for the indicator "3.3.1 New HIV infections (per 1000 uninfected population) - Male" across African nations, sourced from the World Health Organization's (WHO) data portal on Sustainable Development Goals (SDGs). The data is presented… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/hiv-infections-male-for-african-countries.

This dataset is about countries per year in South America. It has 768 rows. It features 4 columns: country, urban population living in areas where elevation is below 5 meters , and incidence of HIV.

This dataset contains surveillance study estimates for population size, HIV prevalence, and ART coverage among female sex workers (FSW), men who have sex with men (MSM), people who inject drugs (PWID), and transgender men and women (TGM/W) from 2010-2023. It was created to support the UNAIDS Estimates Key Population Workbook for use by HIV estimates teams in sub-Saharan Africa. Key population surveillance reports, including Ministry of Health-led biobehavioural surveys, mapping studies, and academic studies were used to populate the database.

The dataset was populated using existing key population size estimate databases including:

• UNAIDS Key Population Atlas
• US Centers for Disease Control and Prevention surveillance database
• Global Fund against HIV/AIDS, TB, and Malaria surveillance database
• Global.HIV database
• Systematic review databases among MSM (Stannah et al, 2019 and Stannah et al., 2023) and PWID (Degenhardt et al., 2023)

and was additionally supplemented by a literature review of peer-reviewed and grey literature sources.

license: apache-2.0 tags: - africa - sustainable-development-goals - world-health-organization - development

  New HIV infections (per 1000 uninfected population) - Female





  Dataset Description

This dataset provides country-level data for the indicator "3.3.1 New HIV infections (per 1000 uninfected population) - Female" across African nations, sourced from the World Health Organization's (WHO) data portal on Sustainable Development Goals (SDGs). The data is… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/hiv-infections-female-for-african-countries.

The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration. CJ-DATS 2 HIV Services Treatment Implementation in Corrections focused on implementing interventions to address the HIV continuum of care in correctional settings. There are 5 datasets associated with this study. -Dataset 1 (DS1) contains data aggregated at the correction facility level that examines delivery of HIV services in the experimental and control study groups (215 cases). -Dataset 2 (DS2) and Dataset 3 (DS3) detail survey responses from correctional staff about how the HIV services were changed and/or implemented at their facilities (DS2 has 68 cases and DS3 has 85 cases). -Dataset 4 (DS4) contains survey responses from inmates about their perceptions of the HIV services provided at facilities in which they are incarcerated (2,301 cases). -Dataset 5 (DS5) contains data merged together by the principal investigator from several surveys given to treatment staff, treatment directors, correctional officers and correctional directors. This dataset includes demographic information, staff perceptions of their work environment, perceptions of HIV infected individuals, evaluations of HIV workshops and perceptions of the delivery of HIV services at their facility (385 cases). These 5 datasets contain a total of 889 variables.

Updated 10/6/2022: In the Time/Distance analysis process, points that were found to have been included initially, but with no significant or year-round population were removed. The layer of removed points is also available for viewing. MCNA - Removed Population PointsThe Network Adequacy Standards Representative Population Points feature layer contains 97,694 points spread across California that were created from USPS postal delivery route data and US Census data. Each population point also contains the variables for Time and Distance Standards for the County that the point is within. These standards differ by County due to the County "type" which is based on the population density of the county. There are 5 county categories within California: Rural (<50 people/sq mile), Small (51-200 people/sq mile), Medium (201-599 people/sq mile), and Dense (>600 people/sq mile). The Time and Distance data is divided out by Provider Type, Adult and Pediatric separately, so that the Time or Distance analysis can be performed with greater detail. HospitalsOB/GYN SpecialtyAdult Cardiology/Interventional CardiologyAdult DermatologyAdult EndocrinologyAdult ENT/OtolaryngologyAdult GastroenterologyAdult General SurgeryAdult HematologyAdult HIV/AIDS/Infectious DiseaseAdult Mental Health Outpatient ServicesAdult NephrologyAdult NeurologyAdult OncologyAdult OphthalmologyAdult Orthopedic SurgeryAdult PCPAdult Physical Medicine and RehabilitationAdult PsychiatryAdult PulmonologyPediatric Cardiology/Interventional CardiologyPediatric DermatologyPediatric EndocrinologyPediatric ENT/OtolaryngologyPediatric GastroenterologyPediatric General SurgeryPediatric HematologyPediatric HIV/AIDS/Infectious DiseasePediatric Mental Health Outpatient ServicesPediatric NephrologyPediatric NeurologyPediatric OncologyPediatric OphthalmologyPediatric Orthopedic SurgeryPediatric PCPPediatric Physical Medicine and RehabilitationPediatric PsychiatryPediatric Pulmonology

Number of cases attributable to heterosexual contact, statistically adjusted to account for reporting delays and missing risk factor information, but not for incomplete reporting.†Per 100,000 heterosexuals.§ Hispanics/Latinos may be of any race.¶ Other race includes American Indian/Alaska Native, Native Hawaiian/Other Pacific Islander, unknown race/ethnicity, and multiple races.* Relative standard error >30% for meta-analysis estimate of the population proportion heterosexual for this group.Note. Data include persons age 13 years and older with a diagnosis of HIV infection regardless of stage of disease at diagnosis. CI = confidence interval

Users can obtain demographic, maternal and child health, and development information regarding countries with whom UNICEF works. BackgroundUNICEF (United Nations Children Fund) is a non-governmental agency that works with governments, national and international agencies and communities to reduce the cycle of poverty in more than 150 countries and territories. UNICEF’s programs address child health and nutrition, safe water and sanitation, gender-equitable quality basic education, and the protection of children from violence, exploitation and AIDS. Topics include: country demographics, basic health, HIV/AIDS , education, and economics, among others. User Functionality Users can obtain information regarding countries with whom UNICEF works. UNICEF provides a background of each country; indicators such as country demographics, basic health, HIV/AIDS, nutrition, education, economics, child protection, women’s health and status, and rate of progress; information regarding UNICEF initiatives in the country; and news regarding current events relevant to the well-being of its residents, the impact of UNICEF and similar programs, as well as the impact of epidemics, natural disaster and political conflicts on children. Users can obtain country summaries and health indicators for each country. Maps can be downloaded as PDF files. Data Notes Data are derived from multiple sources including: UNICEF, the United Nations Population Division, United Nations Statistics Division, Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Educational, Scientific and Cultural Organization (UNESCO), UNESCO Institute of Statistics (including Demographic Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS), Education for All 2000 Assessment), World Health Organization (WHO), Report on the Global HIV/ AIDS Epidemic, US Census Bureau, HIV/AIDS Surveillance Database, Behavioral Surveillance Surveys (BSS), Reproductive Health Surveys (RHS), International Telecommunications Union, Yearbook of Statistics, Children on the Brink, World Bank, International Monetary Fund (IMF), Organization for Economic Co-operation and Development (OECD) and national household surveys and routine reporting systems. Years to which the data apply is noted with the relevant indicator. Data updates vary according to indicator, and can be found under the “Definitions and Data Source” tab. Information is available on the country level.

Contains data from the World Bank's data portal. There is also a consolidated country dataset on HDX.

Improving health is central to the Millennium Development Goals, and the public sector is the main provider of health care in developing countries. To reduce inequities, many countries have emphasized primary health care, including immunization, sanitation, access to safe drinking water, and safe motherhood initiatives. Data here cover health systems, disease prevention, reproductive health, nutrition, and population dynamics. Data are from the United Nations Population Division, World Health Organization, United Nations Children's Fund, the Joint United Nations Programme on HIV/AIDS, and various other sources.

Early initiation of antiretroviral therapy (ART) reduces morbidity and mortality for individuals infected with HIV. Suppressing viral replication with ART also reduces the potential for transmission of HIV. Hence, ART is recommended for all persons with HIV viremia regardless of cluster of differentiation 4 (CD4) count. This is an open-label single arm which will evaluate the feasibility, efficacy and safety using a fixed dose combination (FDC) of Dolutegravir (DTG) plus Lamivudine (3TC) as a first line regimen of a rapid Test and Treat model of care over 48 weeks. Participants with new and confirmed diagnosed HIV-1 who are willing to start study treatment immediately following diagnosis will receive 50 milligram (mg) DTG + 300 (mg) 3TC FDC as first line therapy without waiting for screening laboratory results, at the Screening/Day 1 Visit. The total duration for the study will be 52 weeks and 4 weeks of follow up period if required. This study will be conducted in United States (US) with approximately 120 participants.

The Sexually Transmitted Disease (STD) Morbidity online databases on CDC WONDER contain case reports reported from the 50 United States and D.C., Puerto Rico, Virgin Islands and Guam. The online databases report the number of cases and disease incidence rates by year, state, disease, age, sex of patient, type of STD, and area of report. Data are produced by the U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, viral Hepatitis, STD and TB Prevention (NCHHSTP).

The Hepatitis category in NYC Health Map provides a list of facilities for the public and service providers looking for prevention services, testing, and treatment for hepatitis B and C. Due to shared risk factors, people living with HIV should get the Hep B vaccine, and should get tested for both Hep B and C. The programs listed have been verified by the NYC DOHMH. https://a816-healthpsi.nyc.gov/NYCHealthMap The Viral Hepatitis Program in the Bureau of Hepatitis, HIV and STI contracts with organizations in the city to provide peer navigation and patient navigation for Hep B and C. These agencies and their hepatitis services are listed in the NYC Health Map for public use. The Hepatitis list also includes agencies contracted by the New York State Health Department to provide Hep C testing, care and treatment, and agencies participating in the Hep Free NYC network. This list is maintained in a database by Viral Hepatitis Program staff and is updated once a year. It does not capture all hepatitis B and C services available in New York City. The data is organized by service type, and each record represents a service offered at a single _location. Hepatitis A vaccine information is kept separately in the Vaccines list managed by the Bureau of Immunizations.